Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults

por Martinón-Torres, Federico, Nolan, Terry, Toneatto, Daniela, Banzhoff, Angelika
Publicado 2019

Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and...

por Beran, Jiří, Dražan, Daniel, Enweonye, Igwebuike, Bhusal, Chiranjiwi, Toneatto, Daniela
Publicado 2021

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program

por O’Ryan, Miguel, Stoddard, Jeffrey, Toneatto, Daniela, Wassil, James, Dull, Peter M.
Publicado 2013

Persistence of Bactericidal Activity at 4 Years After 2 Primary Doses of a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Ad...

por Nolan, Terry, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, Marshall, Helen, D’Agostino, Diego, Toneatto, Daniela
Publicado 2017

Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

por Sáez-Llorens, Xavier, Beltran-Rodriguez, Johnny, Novoa Pizarro, Jose M., Mensi, Ilhem, Keshavan, Pavitra, Toneatto, Daniela
Publicado 2018

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study

por Chiu, Nan-Chang, Huang, Li-Min, Willemsen, Arnold, Bhusal, Chiranjiwi, Arora, Ashwani Kumar, Reynoso Mojares, Zenaida, Toneatto, Daniela
Publicado 2018

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules

por Biolchi, Alessia, Tomei, Sara, Santini, Laura, Welsch, Jo Anne, Toneatto, Daniela, Gaitatzis, Nikolaos, Bai, Xilian, Borrow, Ray, Giuliani, Marzia Monica, Mori, Elena, Pizza, Mariagrazia
Publicado 2019

Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phas...

por Vesikari, Timo, Brzostek, Jerzy, Ahonen, Anitta, Paassilta, Marita, Majda-Stanislawska, Ewa, Szenborn, Leszek, Virta, Miia, Clifford, Robert, Jackowska, Teresa, Kimmel, Murray, Bindi, Ilaria, Keshavan, Pavitra, Pedotti, Paola, Toneatto, Daniela
Publicado 2021

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269

por Stella, Maria, Giuliani, Maria, Biolchi, Alessia, Tomei, Sara, De Paola, Rosita, Bai, Xilian, Borrow, Ray, Lucidarme, Jay, La Gaetana, Rita, Toneatto, Daniela, Pizza, Mariagrazia, Serino, Laura, Mori, Elena, Giuliani, Marzia Monica
Publicado 2019

152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Boo...

por Nolan, Terry, O’Ryan, Miguel, Santolaya, María Elena, De Looze, Ferdinandus, Marshall, Helen, Richmond, Peter, Henein, Sam, Rheault, Paul, Heaton, Ken, Perrett, Kirsten, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, D’Agostino, Diego, Toneatto, Daniela
Publicado 2018